Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.
about
Molecular testing for the clinical diagnosis of fibrolamellar carcinoma.Fibrolamellar Carcinoma in the Carney Complex: PRKAR1A Loss Instead of the Classic DNAJB1-PRKACA Fusion.Intracranial metastasis in fibrolamellar hepatocellular carcinoma.Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods.Environmental exposures as a risk factor for fibrolamellar carcinoma.
P2860
Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Hepatic adenomas with synchron ...... e characterized by LFABP loss.
@en
Hepatic adenomas with synchron ...... e characterized by LFABP loss.
@nl
type
label
Hepatic adenomas with synchron ...... e characterized by LFABP loss.
@en
Hepatic adenomas with synchron ...... e characterized by LFABP loss.
@nl
prefLabel
Hepatic adenomas with synchron ...... e characterized by LFABP loss.
@en
Hepatic adenomas with synchron ...... e characterized by LFABP loss.
@nl
P2093
P2860
P1433
P1476
Hepatic adenomas with synchron ...... re characterized by LFABP loss
@en
P2093
Alexander Meves
Luigi M Terracciano
Matthew M Yeh
Michael S Torbenson
Michael W Cruise
Patrick M Vanderboom
Surendra Dasari
P2860
P2888
P304
P356
10.1038/MODPATHOL.2016.59
P577
2016-03-25T00:00:00Z